The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour.
Markets are closely watching Ueda’s post-meeting news conference for clues on how US President Donald Trump’s tariffs would affect the BOJ’s rate-hike...